Objective: To understand the impact of the Hospital Readmission Reduction Program on both future targeted and nontargeted surgical procedures. Background: The Hospital Readmission Reduction Program, established under the Affordable Care Act in March of 2010, placed financial penalties on hospitals with higher than expected rates of readmission beginning in 2012 for targeted medical conditions. Multiple studies have suggested a ''spillover'' effect into other conditions, but the extent of that effect for specific surgical procedures is unknown. Methods: A retrospective review 5,122,240 Medicare beneficiaries who underwent future targeted procedures (total hip replacement, total knee replacements) or nontargeted procedures (colectomy, lung resection, abdominal aortic aneurysm repair, coronary artery bypass graft, aortic valve replacement, mitral valve repair) using an interrupted time series model to assess the rates of readmission before the Hospital Readmission Reduction Program was announced (2008)(2009)(2010), whereas the program was being implemented (2010-2012) and after penalties were initiated (2012)(2013)(2014). We also explored if the change in readmission rates were correlated with changes in index length of stay, use of observation status, or discharge to a skilled nursing facility. Results: From 2008 to 2014 rates of readmission declined for both target conditions (6.8%-4.8%; slope change À0.07 to À0.10, P < 0.001) and nontarget conditions (17.1%-13.4%; slope change À0.04 to À0.11, P < 0.001). The rate of reduction was most prominent after announcement of the program between 2010 and 2012 for both targeted and nontargeted conditions. During the same time period, mean hospital length of stay decreased; nontargeted conditions (10.4-8.4 days) and targeted conditions (3.6-2.8 days). There was no correlation between hospital reduction in readmissions and use of observation-only admissions (Pearson correlation coefficient ¼ 0.01) or discharge to a skilled nursing facility (Pearson correlation coefficient ¼ 0.05). Conclusions: Trends in readmissions after inpatient surgery are consistent with hospitals responding to financial incentives announced in the Hospital Readmission Reduction Program. There appears to be both an anticipatory effect (future targeted procedures reducing readmission before payments implemented) and a spillover effect (nontargeted procedures also reducing readmissions).
R
eadmissions after inpatient hospitalizations are common, costly, and in many cases may be preventable. In 2009, a review of Medicare beneficiaries observed that 19.6% patients were readmitted within 30 days of discharge. 1 Moreover, the study found that Medicare paid more than $17 billion annually on unplanned rehospitalizations suggesting that readmissions could be an important target for quality improvement. Building on these findings, the Affordable Care Act announced the Hospital Readmission Reduction Program in 2010. Under this policy, hospitals with higher than expected readmissions rates beginning in 2012 for 3 common medical conditions-myocardial infarction, heart failure, pneumonia-would be subject to payment penalties. A growing number of studies now support that the program has led to significant reductions in readmissions rates for these targeted medical procedures. 2, 3 Whether or not the Hospital Readmissions Reduction Program had any impact on readmission rates for surgical procedures remains understudied. On the one hand, hospital efforts to prevent readmissions may have been purposefully focused on the targeted medical conditions in which penalties were being enforced. In contrast, hospitals may have taken a more comprehensive approach to prevent readmissions by investing in system and network-wide resources that improve coordination of care. 4 Hospitals would have reason to pursue this broader systems-based approach as the Hospital Readmission Reduction Program had the stated goal of expanding penalties at a future date to additional conditions, including specific surgical procedures. In fact, the most recent evaluation of program identified that several conditions beyond the initial 3 target medical conditions experienced reduction in readmission rates, suggesting a ''spill-over'' effect of the policy. Whether or not this spillover effect exists for specific surgical cohorts, however, remains unknown.
In that context, we designed a study to understand the impact of the Hospital Readmission Reduction Program on both future targeted and nontargeted surgical procedures. In addition to understanding the overall trend in readmission rates before and after the policy, we also explored if the changes in readmission rates could be explained by concurrent changes in length of stay during initial admission, use of observation status, or discharge to skilled nursing facility (SNF).
METHODS

Data Source and Population
We used data from the Medicare Provider Analysis and Review (MedPAR) file including procedures from 2008 to 2014. This represented 7 years of the most recent data available from the Centers for Medicare and Medicaid Services. Moreover, it importantly spanned a time period before and after the Hospital Readmission Reduction Program was announced and implemented so than trends could be adequately assessed.
International Classification of Disease-Clinical Modification, 9th Edition codes were used to identify a total of 8 different surgical procedures. Specifically, we included patients undergoing procedures that are being targeted in the future by the Hospital Readmission Reduction Program (total hip replacement, total knee replacements) and nontargeted procedures (colectomy, lung resection, abdominal aortic aneurysm repair, coronary artery bypass graft, aortic valve replacement, mitral valve repair). Of note, in 2015 coronary artery bypass graft was added to the list of future targeted procedures. Because, however, our present data included procedures through only 2014, we categorized coronary artery bypass graft as a nontargeted procedure.
Hospitals included in this study were identified by their provider number in the MedPAR file. By linking the MedPAR file with data from the American Hospital Association Annual Survey, 5 additional information about each hospital was obtained to better understand any associations with their rates of readmissions.
Consistent with definitions used by the Centers for Medicare and Medicaid Services, we excluded patients who experienced mortality during the index admission. 6 In addition, 416 hospitals and 78,575 patients were excluded because they did not include adequate pre-and postdata surrounding the Hospital Readmission Reduction Program. This study was approved by the institutional review board at the University of Michigan and deemed exempt due to use of secondary data.
Outcomes
Rate of Readmissions
The primary outcome in this study was the rate of readmission after the index admission. We applied definitions for readmissions as outlined by the Hospital Readmission Reduction Program. 7 Briefly, this included any readmission within 30 days of discharge from an index hospitalization where the procedure was performed.
Rates of readmissions were risk adjusted in a manner consistent with the measure specifications outlined by the Hospital Readmission Reduction Program. This was performed using a multivariable logistic regression model that included patient demographic characteristics and patient comorbidities as defined by Elixhauser et al 8 and Southern et al. 9 For comparison across hospitals, we added the type of procedure into our risk-adjustment model.
Length of Stay, Observation Status, Skilled Nursing Facility
Length of stay was assessed because previous reports have suggested that a shorter length of stay may put patients at higher risk of a readmission. 10 Therefore, we wanted to evaluate whether, overtime, hospitals may have kept patients in the hospital longer in an effort to avoid a readmission. Length of stay was calculated within MedPAR data by subtracting the day of discharge from the date of the procedure.
Because of concern that hospitals may be gaming the readmission metric by placing patients who return to the hospital in ''observation status,'' 11 we also assessed changes in the rate of observations. We identified observations in the outpatient claims of the MedPAR file using methods described Office of the Inspector General within the Department of Health and Human Services. 12 Use of skilled nursing facilities was determined based on the patient's discharge destination.
Analysis
The first portion of our analysis was to characterize the hospitals, which made the least and most improvement in their rate of readmissions. Change in readmission rate was defined as the difference in the risk-adjusted readmission rate for each hospital before the Hospital Readmission Reduction Program was announced (2008-2010) and after it was implemented (2012-2014). Hospitals were then placed into rank order based on the absolute change in readmission rate and divided into quartiles. Hospitals in the quartile that made the smallest change were labeled ''Least Improved Hospitals,'' whereas those in the quartile that made the largest changed were labeled, ''Most Improved Hospitals.'' Patient and hospital characteristics were compared with between the 2 groups using t test, x 2 test and Wilcoxon rank sum as appropriate. The second step in our analysis was to trend the rate of readmissions for both future targeted and nontargeted surgical procedures before and after the Hospital Readmission Reduction Program was initiated. To do so, we performed an interrupted time series analysis at 3-month intervals using risk-adjusted rates of readmissions for each of the 8 procedures. By doing so, this approach allowed us to adjust for underlying secular trends (eg, adoption of laparoscopy over the study period for studied procedures) that may influence the rate of readmissions. The slope of change for readmissions was assessed during 3 specific time periods related to the Hospital Readmission Reduction Program: before the program was announced (January 2008 to March 2010), whereas the program was being implemented (April 2010 to September 2012) and after penalties were initiated (October 2012 to December 2014). In addition, absolute differences in risk-adjusted readmissions rates were determined for each procedure comparing the mean rate before the program was announced and after it was implemented.
The next portion of our analysis was to assess whether the change in rates of readmissions was associated with changes in length or stay. Length of stay was trended in a similar fashion as readmissions using an interrupted time series to ultimately compare the mean length of the stay before announcement and after implementation of the Hospital Readmission Reduction Program.
Finally, we wanted to assess whether the change in readmission rates had any relationship, at the hospital level, with the use of observation status admissions. We plotted the hospital-level absolute differences in readmission rates against the absolute change in observation status. A Pearson correlation coefficient was used to assess both the strength and directionality.
All analyses were performed using STATA 14 (Stata Corp, College Station, TX). All tests were 2-tailed using 0.05 as the threshold for significance.
RESULTS
A total of 5,122,240 patients (average age 74.5; 43.3% men; 90.3% white) were included in our study (Table 1) . Compared to hospitals with the least improved readmissions rates, hospitals who improved their readmission the most were more likely to be nonprofit (71.6% vs 78.4%; P < 0.001) and larger (percentage with >500 beds, 29.7% vs 16.2%). On average, hospitals which improved their readmissions rates the least had a higher proportion of Medicaid days (17.7% vs 16.9%; P < 0.001) and perform fewer operations annually (11,559 vs 16,325; P < 0.001). Overall, each hospital had a mean 2.4% decreased in the rate of readmissions, with the least improved quartile reducing readmissions by 0.5% (9.8%-9.3%) and the most improved quartile by 4.3% (12.7%-8.4%). Additional hospital characteristics are summarized in Table 2 .
All 8 procedures studies improved their readmission rates during the study period (Table 3) . Overall, nontargeted procedures experienced a 3.7% reduction in readmissions rate (17.1%-13.4%; P < 0.001), whereas future targeted procedures experienced a reduction in readmissions rates by 2.0% (6.8%-4.8%). The largest absolute difference was seen in aortic valve replacement (21.7%-16.2%; difference 5.5%).
From 2008 to 2014 rates of readmission declined for both future target conditions (6.8%-4.8%; slope change À0.07 to À0.10, P < 0.001) and nontarget conditions (17.1%-13.4%; slope change À0.04 to À0.11, P < 0.001). The rate of reduction was most prominent after announcement of the program between 2010 and 2012 for both targeted and nontargeted conditions (Fig. 1) . During the same time period, mean hospital length of stay decreased; nontargeted conditions (10.4-8.4 days) and targeted conditions (3.6-2.8 days; Fig. 2 ).
During the study period most hospitals (n ¼ 2190; 70.9%) increased their use of the observation status admission. However, there was no correlation between hospital reduction in readmissions and use of observation-status admissions (Pearson correlation coefficient ¼ 0.01; P ¼ 0.47) (Fig. 3A) . Similarly, we found no correlation between hospital reduction in readmissions and discharge to SNF (Fig. 3B) .
DISCUSSION
The present study has 2 principle findings that improve our understanding of the Hospital Readmissions Reduction Program and surgical readmissions. First, we found that that announcement and implementation of the Hospital Readmissions Reduction Program for target medical conditions had significant spill-over effect on surgical procedures, including both future targeted and nontargeted procedures. Second, we found that changes in hospital length of stay or use of observation status did not account for the overall decrease in readmissions. Taken together, the trends in readmissions reported in this study are consistent with hospitals responding to financial incentives in the Hospital Readmission Reduction Program and making broad systems improvements beyond only the targeted conditions.
Previous studies on the Hospital Readmissions Reduction Program have primarily focused on medical conditions. For example, a study by Zuckerman et al 3 analyzed Medicare beneficiaries admitted for 3 targeted medical conditions-heart failure, pneumonia, myocardial infarction-and found a significant decrease in readmissions for these conditions and other nontargeted conditions. Moreover, they found no correlation between the decrease in readmissions and use of observation status. Our findings in this study mirror those results, and others similarly focused on medical conditions, 13 but with added specificity for both future targeted and nontargeted surgical conditions. Although our study was not designed to identify the exact mechanisms by which hospitals reduced their rate of readmissions for surgical procedures, the data do inform several possible explanations. Although most hospitals during this time period did increase their use of ''observation status'' billing, we found no correlation between use of observation status and a reduction in readmissions. In fact, a sizable proportion of hospitals, which reduced their readmission rate also reduced their use of observation admissions. We also did not find evidence of overt patient selection to reduce readmissions. Hospitals making the most and least improvements in the readmission rates appeared to care for similar patient populations with respect to age, sex, and comorbidities profiles. Finally, because decreases were seen across a diverse selection of 8 procedures in different specialties, it appears most likely that hospitals made broad system wide efforts to reduce readmissions rather than focusing on isolated procedures or conditions. Whether or not readmissions are an appropriate quality metric for surgical patients has been a matter of debate. [14] [15] [16] Particularly in surgical patients, there may in fact be many appropriate or even desired readmissions. For example, a review of surgical readmissions by Merkow et al 17 found the most common reasons for a readmission included a surgical site infection, obstruction, or bleeding. Similarly, Morris et al 18 also noted that a large proportion of surgical readmissions were to manage complications that in some cases may not be avoidable. In such situations, a readmission should be seen as valuable rather than a sign of poor quality care. These reports of appropriate rehospitalizations among surgical patients are an important reminder to temper our enthusiasm for reducing readmissions. In our study, across hospitals who made the least and most improvements in their readmissions rates, they both seem to level out around a readmission rate of 8% to 9% suggesting there may be a ''floor'' for how far readmissions could be reduced for surgical patients. Nonetheless, the large effect size seen here across all 8 procedures examined indicates that at least some surgical readmissions can and should be prevented. Our study should be interpreted within the context of several important limitations. First, by using administrative claims data we may not fully capture the circumstances around a readmission to appropriately risk-adjust rates for hospitals. Several important readmissions studies have identified disparities, 15, 19 systems, 20 and socioeconomic factors 18, 21 not currently included in our risk-adjustment models. Although the Centers for Medicare and Medicaid Services is considering modification to their risk-adjustment methodology, 22, 23 we chose to use the same risk-adjustment framework currently in place to make out findings consistent with other studies assessing also examining Hospital Readmissions Reduction Program in Medicare claims data. 3, [13] [14] [15] 19, 24 Second, our study included only Medicare patients and may not be generalizable to other patient populations (eg, those on private insurance, or in the Veterans Affairs 
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Impact of the Hospital Readmission Reduction Program system) who may also undergo these same surgical procedures. Nonetheless, our findings do seem consistent with other reports in non-Medicare databases that identified a reduction in readmissions after announcement and implementation of the program. Finally, our study cannot definitively state a cause and effect relationship between the Hospital Readmission Reduction Program and reduction in surgical readmissions. Indeed, multiple concurrent efforts to reduce readmissions were happening in parallel given the broad interest from providers to improve coordination of care. However, the effect size and temporal relationship seen in our time series analysis are compelling that the Hospital Readmission Reduction Program at least partially contributed to the overall reductions seen in readmissions for surgical procedures. Our findings have important policy and practice implications related to readmissions and surgical procedures. First, for payers, this study supports the focus on readmissions as a meaningful quality metric that can be incentivized. As the Hospital Readmissions Reduction Program expands to additional conditions, more attention will be needed around identifying truly preventable readmissions in surgical cohorts 17, 25 and accounting for possible socioeconomic confounders. Second, for providers and hospitals administrators, these findings should be encouraging. The efforts to reduce readmissions for targeted conditions seem to have a sizeable impact on those procedures, and additional procedures that were not targeted.
Finally, for patients these findings should mark another example of payers and providers attempting to align incentives that ultimately delivers higher quality care.
CONCLUSIONS
The trends in readmissions after inpatient surgery reported in this study are consistent with hospitals responding to financial incentives in the Hospital Readmission Reduction Program and making broad systems improvements. There appears to be both an anticipatory effect (future targeted procedures reducing readmission before payments implemented) and a spillover effect (nontargeted procedures also reducing readmissions). As the program expands to target more surgical conditions, more attention will be needed on better risk-adjustment models that account for appropriate readmissions and socioeconomic confounders.
It's truly my privilege to discuss this important and interesting article evaluating the hospital readmission reduction program by Dr Ibrahim and colleagues.
Using Medicare records, they assessed the impact of the hospital readmission reduction program on readmissions before, during, and after the implementation and employed an elegant time series analysis to account for the secular trends.
The authors, as you have just heard, identified that rates of readmission were reduced for both targeted and nontargeted procedures during the study period and at approximately the same magnitude, although slightly less for the targeted. Hospitals with the highest readmission rates had the largest decrease in readmission rates, and those in the lowest quartile at the baseline rates had similar baseline rates to what ultimately the high readmission hospitals were able to achieve.
So my question for you, is there a floor effect? Can we really get much more improvement on readmissions than you have observed over your study period?
Your findings and attribution to the implementation of the readmission reduction program could have several alternative hypotheses exist. You were diligent in testing 2 of these, including whether readmissions were switched to observations or whether patients were kept longer in the hospital and found no effect of these 2 potential mechanisms.
A third hypothesis along these same lines would be were patients discharged to skilled nursing facilities or other destinations other than home that could potentially be associated with lower readmissions? And also, did you look at postdischarge mortality to make sure that that was not another alternative mechanism to decreased readmissions?
Another hypotheses that I thought of, especially when I looked at your data and was intrigued by, was whether there was an effect of adoption of technology. We have seen major innovative changes in the way that we do operations that are less morbid for our patients, such as the transcatheter aortic valve replacement, minimally invasive gastrointestinal surgery, and so on. We know that these lead to fewer complications and likely that effect alone will reduce readmissions. I think your data are intriguing in this area.
Finally, prior work has demonstrated that hospitals make money from complications and readmissions. Do you have any plans to understand the financial impact of readmission reductions on the hospital bottom line? We all feel our own hospitals' bottom lines are being squeezed, leaving fewer dollars to invest in equipment and technology upgrades. Hospitals will need healthy margins to continue to provide the excellent improvements and care that your study has demonstrated.
Again, congratulations on an incredibly well-done and wellpresented article.
Dr Andrew M. Ibrahim (Ann Arbor, MI):
Thank you so much, Dr Hawn. I will answer your questions in order.
First, is there a floor for surgical readmissions? I think it's important to note that zero is not necessarily the goal. There are, again, many readmissions that may be appropriate for surgical patients. Within the limitations of claims data, we had a hard time teasing out appropriateness, so we did not do that. However, we do plan in the future to repeat this analysis within our clinical registries in Michigan to try to tease out better how many of these readmissions are appropriate and what the true floor might be.
Your second question regarding discharge destination and whether or not use of SNF or mortality could potentially be gaming our results. Currently under the policy rule, if a patient dies during the episode, they are excluded from the policy and not counted in the numerator or denominator, so those patients were excluded from our study.
As for SNF, we initially looked at observation use and length of stay because that's been written about significantly with the use of postdischarge acute care, and SNF would certainly be important, and we can look into that. We had not in our original analysis.
Reasons for readmissions again, something that we will need to do within our clinical registry data and not be able to address adequately in claims.
As for technology, all these procedures were 2014 and prior, and certainly a lot has changed about how we do these operations in the last 3 years. And we certainly agree that the use of minimally invasive approaches could change readmission rates significantly. However, for the majority of procedures that we looked at, the majority were done open during this time period.
And then finally cost. So we have started to evaluate the impact of payments of this policy initially for the targeted medical conditions. And it's good or bad news depending on your perspective. The Centers for Medicare and Medicaid perspective, this policy is great for payments because it appears that payments went down. What that means for hospitals is actually that revenue is going down. So that will certainly propose a challenge as this policy is modified and applied for surgery.
Dr. Donald Fry (Chicago, IL):
I certainly enjoyed this presentation. We have spent a lot of time filtering through the Medicare data. We have put risk factors for the year of the procedure and we put dummy variables into the prediction equations. We see a decline in readmissions that is uniform across the country for the last several years that appears to be occurring across all hospitals.
From Medicare date in the year 2016, there were 2665 hospitals out of the 41,000 eligible hospitals that had money clawed back by CMS for excessive readmissions. Then for 2017, there were only 68 fewer hospitals that sustained the readmissions penalty by CMS, but the total penalty assessed against all hospitals by CMS increased by $108 million. Thus, we are seeing two-thirds of all hospitals getting readmission penalties. CMS has set a standard on readmissions that two-thirds of hospitals cannot meet.
We have studied readmissions more than 90 days after discharge and not just 30 days. The Comprehensive care for Joint Replacement program and the cardiac care bundles proposed by CMS will have 90 days of postdischarge responsibility for the hospital. We find that 40% to 45% of relevant readmissions are identified from day 31 to 90 after discharge. So I am curious whether you have identified evidence that readmissions are being pushed back past 30 days after discharge to avoid the penalties of the readmission reduction program by CMS? Dr Andrew M. Ibrahim (Ann Arbor, MI):
Thank you so much, Dr Fry, for those important questions. I will say the appropriateness has been challenging. Certainly the policy has been criticized quite a bit in light of how many hospitals have been penalized. We tried to stick as closely as possible to the same criteria as Medicare. In a separate future analysis, I think it will be important to look at these other risk factors and see how much it changes the readmission rate, particularly for safety net hospitals and rural hospitals, which appear will probably be penalized by these the most. I think that will be quite important.
As for 30 or 90 days, this seems to be a topic for almost every Medicare policy. We evaluated 30 days because that is the rule as currently written, and in other Medicare policies where they have looked at mortality rate as the primary policy, there have been recent articles in Annals of Surgery evaluating whether there was gaming that mortality increased on day 31 or 32, and no evidence of that. But I agree, that would be important to evaluate for this policy as well.
Dr David Spain (Stanford, CA):
Nice presentation. In an article in the Journal of Hospital Medicine in September 2016, a group from Hopkins looked at readmission rates for a number of medical diagnoses and coronary bypass grafting and showed that many of the hospitals that were in the worst tertile for readmissions were actually in the lowest tertile for mortality rates. Did you look at mortality rates in this study, comparing those hospitals that improved the most and those that improved the least? Also, could you envision a composite quality score where not only do we look at length of stay, but also readmissions and risk-adjusted mortality rates?
Dr Andrew M. Ibrahim (Ann Arbor, MI):
Thank you for that question, Dr Spain. I think one of the reactions when we initially looked at these results were that these readmission rates are dropping quite significantly and maybe appropriately wondered if it's too good to be true.
One of the points that's interesting is mortalities are excluded from this cohort to evaluate the policy because they do not count. We did not include mortality in this, but a composite measure may be a more appropriate step to do that. I would include in that list transfers as well. So transferred patients, interestingly, depending on how it's claimed, may also be excluded the way Centers for Medicare and Medicaid has this policy. We are planning in a future analysis to test for that as well.
Dr Thomas Tracy (Hershey, PA):
This is a great article. Your introduction pointed out the initial targets of congestive heart failure (CHF) and acute myocardial infarction. As the data have matured around CHF, there is a movement that's afoot called ''One More Day.'' I think that people are learning there are certain conditions or certain patient subsets within conditions such as CHF that could use another day in the hospital for more aggressive treatment to limit readmissions.
I wonder if in your dataset you are able to see either a floor or a ceiling, for certain subsets such as these, especially if your targeted conditions that would indicate that you just cannot budge any further on length of stay. Perhaps, as was pointed out in Mary's article, that better or longer care, whether it's pain control or some other extended intervention might actually have a beneficial effect on readmissions, but at the expense of another day in the hospital. Thank you.
Dr Andrew M. Ibrahim (Ann Arbor, MI):
Thank you so much. In our evidence, the slope actually continued quite steady through both interruptions on length of stay that continued to decrease, but already length of stay for the target procedure is already down to 2 days. So the idea that it would continue to decrease is likely unlikely in that we are probably pretty close to a floor. But it's certainly a potential unintended consequence of getting patients out the door earlier to try to reduce their length of stay and, as a result, having a readmission. So it's certainly worthy of more work.
